Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin Attenuates Sorafenib-Induced Myocardial Inflammation and Toxicity
- Type
- Retraction
- Notice date
- 10/24/2025 0:00
- Journal
- Environmental Toxicology
- Publisher
- Wiley
- Notice DOI
- 10.1002/tox.24590
- Original paper DOI
- 10.1002/tox.24362